• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同数学方法对依托泊苷曲线下面积估计及药效学反应预测的影响。

Effect of different mathematical methods on etoposide area under the curve estimations and pharmacodynamic response predictions.

作者信息

McCauley D L, Lum B L, Sikic B I

机构信息

State University of New York at Stony Brook 11794, USA.

出版信息

Cancer Chemother Pharmacol. 1996;37(3):286-8. doi: 10.1007/BF00688330.

DOI:10.1007/BF00688330
PMID:8529291
Abstract

Different methods to calculate interval area under the curve (AUC) data may produce substantial error. The purpose of this study was to compare methods of calculating etoposide AUC and determine the effect of these values on white blood cell (WBC) count nadir predictions calculated from a previously reported equation. Three AUC calculation methods were used: (1) the linear trapezoidal method, (2) a combination of the linear and logarithmic trapezoidal methods, and (3) the Lagrange method. Since none of the methods for determining the AUC could be considered the standard, the methods were evaluated by comparing differences between pairs of calculated AUC values by each method. The 95% CI for differences between all pairs of AUC values were greater than zero (no difference) indicating significance. Consistent with the smoother fitting function between data points, the Lagrange method tended to produce a larger AUC, lower clearance values, and lower WBC nadir count predictions than the other methods. The largest difference encountered was between the Lagrange and the linear-log AUC methods with a mean value of 16.9 micrograms h/ml (95% CI 9.4-24.3) This difference would account for approximately 11% of the total AUC. Using a previously published equation, where WBC nadir = -0.057 +0.048 x etoposide clearance, with clearance determined as dose/AUC, mean differences in calculated WBC nadir count values between the three AUC methods ranged from 80 to 220 cells/microliters, which would be expected to be of little clinical consequence. The precision of this equation, using data derived from linear trapezoidal AUC calculations, had a mean absolute error of 0.93 x 10(3)/microliters (95% CI 0.53-1.32). Our findings suggest that any of the three mathematical methods studied would produce similar etoposide AUC values and pharmacodynamic predictions. Further, these findings also suggest that the major limitation in predicting etoposide leukopenia lies with the imprecision of the pharmacodynamic model more so than the ability to accurately determine the AUC. However, our findings may not be applicable if other factors intervene which dramatically alter the shape of the etoposide concentration-time curve.

摘要

计算曲线下面积(AUC)数据区间的不同方法可能会产生显著误差。本研究的目的是比较依托泊苷AUC的计算方法,并确定这些值对根据先前报道的方程计算的白细胞(WBC)计数最低点预测值的影响。使用了三种AUC计算方法:(1)线性梯形法,(2)线性和对数梯形法的组合,以及(3)拉格朗日法。由于确定AUC的方法均不能被视为标准方法,因此通过比较每种方法计算的AUC值对之间的差异来评估这些方法。所有AUC值对之间差异的95%置信区间大于零(无差异),表明具有显著性。与数据点之间更平滑的拟合函数一致,拉格朗日法往往比其他方法产生更大的AUC、更低的清除率值和更低的WBC最低点计数预测值。遇到的最大差异是拉格朗日法与线性-对数AUC法之间的差异,平均值为16.9微克·小时/毫升(95%置信区间9.4 - 24.3)。这种差异约占总AUC的11%。使用先前发表的方程,其中WBC最低点=-0.057 + 0.048×依托泊苷清除率,清除率定义为剂量/AUC,三种AUC方法之间计算的WBC最低点计数值的平均差异范围为80至220个细胞/微升,预计这在临床上几乎没有影响。使用从线性梯形AUC计算得出的数据,该方程的精度平均绝对误差为0.93×10³/微升(95%置信区间0.53 - 1.32)。我们的研究结果表明,所研究的三种数学方法中的任何一种都会产生相似的依托泊苷AUC值和药效学预测。此外,这些研究结果还表明,预测依托泊苷引起的白细胞减少的主要限制在于药效学模型的不精确性,而不是准确确定AUC的能力。然而,如果其他因素介入并显著改变依托泊苷浓度-时间曲线的形状,我们的研究结果可能不适用。

相似文献

1
Effect of different mathematical methods on etoposide area under the curve estimations and pharmacodynamic response predictions.不同数学方法对依托泊苷曲线下面积估计及药效学反应预测的影响。
Cancer Chemother Pharmacol. 1996;37(3):286-8. doi: 10.1007/BF00688330.
2
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.在一项逆转P-糖蛋白(MDR1基因)介导的耐药性试验中,大剂量环孢素对依托泊苷药效学的影响。
Cancer Chemother Pharmacol. 2000;45(4):305-11. doi: 10.1007/s002800050045.
3
Comparison of three methods for cyclosporine area under the curve monitoring calculations.三种环孢素曲线下面积监测计算方法的比较。
Ther Drug Monit. 1995 Jun;17(3):305-7. doi: 10.1097/00007691-199506000-00015.
4
Validation of a limited sampling model to determine etoposide area under the curve.用于确定依托泊苷曲线下面积的有限采样模型的验证
Pharmacotherapy. 1997 Sep-Oct;17(5):887-90.
5
Predicting etoposide toxicity: relationship to organ function and protein binding.
J Clin Oncol. 1996 Jan;14(1):257-67. doi: 10.1200/JCO.1996.14.1.257.
6
Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.口服依托泊苷治疗小细胞和非小细胞肺癌患者的临床药理学
Clin Cancer Res. 1995 Dec;1(12):1517-24.
7
Indirect-response model for the time course of leukopenia with anticancer drugs.
Clin Pharmacol Ther. 1998 Nov;64(5):511-21. doi: 10.1016/S0009-9236(98)90134-5.
8
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer.转移性乳腺癌女性患者口服依托泊苷长效制剂的药代动力学和药效学
Cancer Chemother Pharmacol. 1995;37(1-2):161-7. doi: 10.1007/BF00685644.
9
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer.依托泊苷每日一次连续三日静脉输注治疗广泛期小细胞肺癌的药效学研究
Cancer Chemother Pharmacol. 1992;31(2):161-6. doi: 10.1007/BF00685105.
10
A limited sampling method for estimation of the etoposide area under the curve.一种用于估计依托泊苷曲线下面积的有限采样方法。
Cancer Chemother Pharmacol. 1993;32(3):226-30. doi: 10.1007/BF00685840.

本文引用的文献

1
Some suggestions for measuring predictive performance.一些关于衡量预测性能的建议。
J Pharmacokinet Biopharm. 1981 Aug;9(4):503-12. doi: 10.1007/BF01060893.
2
LAGRAN program for area and moments in pharmacokinetic analysis.药代动力学分析中用于面积和矩的LAGRAN程序。
Comput Programs Biomed. 1983 Jun;16(3):203-16. doi: 10.1016/0010-468x(83)90082-x.
3
Pharmacodynamics in cancer therapy.癌症治疗中的药效学
J Clin Oncol. 1990 Oct;8(10):1739-53. doi: 10.1200/JCO.1990.8.10.1739.
4
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.
J Clin Oncol. 1992 Oct;10(10):1635-42. doi: 10.1200/JCO.1992.10.10.1635.
5
Pharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer.依托泊苷每日一次连续三日静脉输注治疗广泛期小细胞肺癌的药效学研究
Cancer Chemother Pharmacol. 1992;31(2):161-6. doi: 10.1007/BF00685105.
6
Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.对使用线性梯形法则方法计算血浆浓度-时间曲线下面积的药代动力学研究中潜在误差的批判性评估。
J Pharmacokinet Biopharm. 1978 Dec;6(6):539-46. doi: 10.1007/BF01062108.
7
A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.
J Pharmacokinet Biopharm. 1978 Feb;6(1):79-98. doi: 10.1007/BF01066064.